Abstract
Nosocomial bacterial pneumonia (NBP) was once considered a common cause of morbidity and mortality among advanced AIDS patients. However, clinical and microbiological characteristics and outcome-associated risk factors in this population are poorly defined. We conducted a retrospective study of all HIV-infected patients admitted during the period 1988-2002 at the Infectious Diseases Clinic of Milan, Italy, to determine incidence rate and factors affecting mortality of NBP, and to gather clinical and microbiological findings about the condition. We identified 120 episodes of NBP among 4,967 admissions of HIV-infected individuals. A reduction of incidence became evident after the introduction of highly active antiretroviral therapy (HAART). The more common causative agents were Pseudomonas aeruginosa (33%) Staphylococcus aureus (25%) and Streptococcus pneumoniae (21%). Methicillin resistance was frequent among staphylococci (65%). The mortality rate of NBP was 25.8%. Non-statistically significant factors associated with shorter survival were: CD4(+) count < 10 cells/microl, concomitant lung neoplasm, and complicated roentgenographic picture. Only one factor was significantly associated with lower survival, both in univariate and ...Continue Reading
Citations
Jul 30, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L de Souza GonçalvesA P V Colombo
Jul 14, 2006·The New England Journal of Medicine·Laurence HuangDiane V Havlir
Oct 24, 2012·Clinical Obstetrics and Gynecology·Gweneth B Lazenby
Jan 2, 2007·Current Opinion in Infectious Diseases·Keith P KlugmanCharles Feldman
Oct 7, 2009·Infection and Immunity·Andrew Y KohGerald B Pier
Sep 25, 2008·PloS One·Heather B JaspanLandon Myer
Apr 13, 2012·PLoS Pathogens·Iwona BuciorJoanne N Engel
Jan 1, 2010·Infection and Drug Resistance·Alicia I HidronDavid Rimland
Oct 28, 2011·Clinical Medicine & Research·Vikas PathakRonald L Ciubotaru
Nov 19, 2011·Critical Care Medicine·Annette M Esper, Greg S Martin
Jan 13, 2015·Expert Review of Anti-infective Therapy·Katherine M GaskellRobert S Heyderman
Aug 1, 2007·Expert Review of Respiratory Medicine·Patricia J Dubin, Jay K Kolls
Apr 7, 2011·Chest·Shigeki FujitaniJeremy A Weingarten
May 25, 2013·Clinics in Chest Medicine·John F Murray
Feb 13, 2013·Infectious Disease Clinics of North America·Vanessa YapMark L Metersky
Nov 11, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Marc A BensonDara W Frank
Nov 3, 2007·The Lancet Infectious Diseases·Sandra J BlissOrin S Levine
Apr 27, 2017·SpringerPlus·Goyitom GebremedhnMuthupandian Saravanan
Jun 14, 2019·BioMed Research International·Gebre AdhanomMuthupandian Saravanan
Mar 12, 2020·MBio·Roland ThuenauerWinfried Römer
Jun 27, 2019·Expert Review of Respiratory Medicine·Jerry S Zifodya, Kristina Crothers
Apr 13, 2018·Open Forum Infectious Diseases·Julianna G GardnerDaniel M Musher
Jun 10, 2021·Human Vaccines & Immunotherapeutics·Adoración Navarro-TornéCristina Méndez
Aug 27, 2019·Journal of Medicinal Chemistry·Marwa TaouaiMohammed Benazza